Form 8-K - Current report:
SEC Accession No. 0001193125-23-046827
Filing Date
2023-02-23
Accepted
2023-02-23 17:31:05
Documents
14
Period of Report
2023-02-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d468950d8k.htm   iXBRL 8-K 27420
2 EX-10.1 d468950dex101.htm EX-10.1 13429
3 EX-10.2 d468950dex102.htm EX-10.2 12329
  Complete submission text file 0001193125-23-046827.txt   182333

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aku-20230216.xsd EX-101.SCH 2490
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aku-20230216_lab.xml EX-101.LAB 17971
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aku-20230216_pre.xml EX-101.PRE 11222
8 EXTRACTED XBRL INSTANCE DOCUMENT d468950d8k_htm.xml XML 3446
Mailing Address 8300 W SUNRISE BLVD PLANTATION FL 33322
Business Address 8300 W SUNRISE BLVD PLANTATION FL 33322 9546784489
AKUMIN INC. (Filer) CIK: 0001776197 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39479 | Film No.: 23661202
SIC: 8071 Services-Medical Laboratories